Robert Uhl | Westwicke IR |
Rick Fair | President and CEO |
Atabak Mokari | CFO |
Aaron Foster | Head, Research |
Wangzhi Li | Ladenberg |
Greetings, and welcome to the Bellicum Pharmaceuticals Third Quarter 2019 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
I would now like to turn the conference over to your host Mr. Robert Uhl, Westwicke IR. Please go ahead, sir.